Jacques, C, Béréziat, G, Humbert, L, Olivier, J L, Corvol, M T, Masliah, J, ...
Large amounts of type II-secreted phospholipase A2 (type II sPLA2) are secreted into inflammatory synovial fluid and they are believed to induce the synthesis of lipid mediators by articular...
Arbibe, L, Koumanov, K, Vial, D, Rougeot, C, Faure, G, Havet, N, ...
Lyso-phospholipids exert a major injurious effect on lung cell membranes during Acute Respiratory Distress Syndrome (ARDS), but the mechanisms leading to their in vivo generation are still unknown....
Cholesterol relieves the inhibitory effect of sphingomyelin on type II secretory phospholipase A2.
Koumanov, K S, Quinn, P J, Béréziat, G, Wolf, C
Secretory type II phospholipase A2 (sPLA2) is inhibited by sphingomyelin (SPH); cholesterol either mixed with the model glycerophospholipid substrate or added to the assay medium as separated...
Jacques, C, Béréziat, G, Humbert, L, Olivier, J L, Corvol, M T, Masliah, J, ...
Large amounts of type II-secreted phospholipase A2 (type II sPLA2) are secreted into inflammatory synovial fluid and they are believed to induce the synthesis of lipid mediators by articular...
Arbibe, L, Koumanov, K, Vial, D, Rougeot, C, Faure, G, Havet, N, ...
Lyso-phospholipids exert a major injurious effect on lung cell membranes during Acute Respiratory Distress Syndrome (ARDS), but the mechanisms leading to their in vivo generation are still unknown....
Cholesterol relieves the inhibitory effect of sphingomyelin on type II secretory phospholipase A2.
Koumanov, K S, Quinn, P J, Béréziat, G, Wolf, C
Secretory type II phospholipase A2 (sPLA2) is inhibited by sphingomyelin (SPH); cholesterol either mixed with the model glycerophospholipid substrate or added to the assay medium as separated...